.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Deloitte
Julphar
Federal Trade Commission
Teva
Cipla
Citi
Boehringer Ingelheim
Express Scripts
Moodys

Generated: November 23, 2017

DrugPatentWatch Database Preview

Sonidegib phosphate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sonidegib phosphate and what is the scope of sonidegib phosphate freedom to operate?

Sonidegib phosphate
is the generic ingredient in one branded drug marketed by Sun Pharma Global and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sonidegib phosphate has one hundred patent family members in forty-six countries and ten supplementary protection certificates in eight countries.

There are two drug master file entries for sonidegib phosphate. Two suppliers are listed for this compound.

Summary for sonidegib phosphate

Pharmacology for sonidegib phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma Global
ODOMZO
sonidegib phosphate
CAPSULE;ORAL205266-001Jul 24, 2015RXYesYes► Subscribe► SubscribeYY ► Subscribe
Sun Pharma Global
ODOMZO
sonidegib phosphate
CAPSULE;ORAL205266-001Jul 24, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Sun Pharma Global
ODOMZO
sonidegib phosphate
CAPSULE;ORAL205266-001Jul 24, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: sonidegib phosphate

Country Document Number Estimated Expiration
Japan5603308► Subscribe
LithuaniaPA2015051► Subscribe
HungaryS1500065► Subscribe
San MarinoP200800056► Subscribe
Cuba23860► Subscribe
Ukraine103049► Subscribe
Peru02922011► Subscribe
Honduras2008001652► Subscribe
Ukraine93548► Subscribe
Portugal2363393► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: SONIDEGIB PHOSPHATE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0790Netherlands► SubscribePRODUCT NAME: SONIDEGIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, HYDRAAT OF SOLVAAT; REGISTRATION NO/DATE: EU/1/15/1030 (C(2015)5890) 20150818
5 5026-2015Slovakia► SubscribePRODUCT NAME: SONIDEGIB VO VSETKYCH FORMACH CHRANENYCH ZAKLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/15/1030 20150818
90062-4Sweden► SubscribePRODUCT NAME: SONIDEGIB OR A PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE OR SOLVATE THEREOF; REG. NO/DATE: EU/1/15/1030 20150818
2015051Lithuania► SubscribePRODUCT NAME: SONIDEGIBUM; REGISTRATION NO/DATE: EU/1/15/1030 20150818
2015051,C2021328Lithuania► SubscribePRODUCT NAME: SONIDEGIBAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA, HIDRATAS ARBA SOLVATAS; REGISTRATION NO/DATE: EU/1/15/1030 20150818
883Luxembourg► SubscribePRODUCT NAME: SONIDEGIB OU UN SEL, HYDRATE OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE QUI EN DERIVE; FIRST REGISTRATION: 20150818
2015 00057Denmark► SubscribePRODUCT NAME: SONIDEGIB ELLER ET FARMACEUTISK ACCEPTABELT SALT, HYDRAT ELLER SOLVAT DERAF, HERUNDER SONIDEGIBFOSFAT; REG. NO/DATE: EU/1/15/1030 20150818
2015 00057Denmark► SubscribePRODUCT NAME: SONIDEGIB ELLER ET FARMACEUTISK ACCEPTABELT SALT, HYDRAT ELLER SOLVAT DERAF, HERUNDER SONIDEGIBFOSFAT; REG. NO/DATE: EU/1/15/1030 20150818
2016000001Germany► SubscribePRODUCT NAME: SONIDEGIB ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ, HYDRAT ODER SOLVAT HIERVON; REGISTRATION NO/DATE: EU/1/15/1030 20150814
C0077France► SubscribePRODUCT NAME: SONIDEGIB OU SEL,HYDRATE,OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/15/1030 20150818
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Daiichi Sankyo
Merck
Fish and Richardson
Novartis
Dow
Fuji
Accenture
Federal Trade Commission
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot